177 related articles for article (PubMed ID: 36176854)
1. Treatment and Outcomes of Unifocal and Multifocal Osseous Pelvic Langerhans Cell Histiocytosis Lesions in a Pediatric Population.
Mitchell P; Ezeokoli EU; Borici N; Schleh E; Montgomery N
Cureus; 2022 Aug; 14(8):e28470. PubMed ID: 36176854
[TBL] [Abstract][Full Text] [Related]
2. Presentation, treatment, and outcomes of unifocal and multifocal osseous vertebral Langerhans cell histiocytosis lesions in patients under 18 years old.
Ezeokoli EU; Smith T; Mitchell P; Schlehr E; Borici N; Montgomery N
J Pediatr Orthop B; 2024 May; 33(3):274-279. PubMed ID: 37278277
[TBL] [Abstract][Full Text] [Related]
3. Does adjunctive chemotherapy reduce remission rates compared to cortisone alone in unifocal or multifocal histiocytosis of bone?
Baptista AM; Camargo AF; de Camargo OP; Odone Filho V; Cassone AE
Clin Orthop Relat Res; 2012 Mar; 470(3):663-9. PubMed ID: 22052526
[TBL] [Abstract][Full Text] [Related]
4. Langerhans cell histiocytosis of skull: a retrospective study of 18 cases.
Zhang XH; Zhang J; Chen ZH; Sai K; Chen YS; Wang J; Ke C; Guo CC; Chen ZP; Mou YG
Ann Palliat Med; 2017 Apr; 6(2):159-164. PubMed ID: 28061539
[TBL] [Abstract][Full Text] [Related]
5. Approaches to treatment of unifocal langerhans cell histiocytosis: is biopsy alone enough?
Rivera JC; Wylie E; Dell'Orfano S; Mooney R; Hensley MA; Carry P; Monreal AK; Heare T
J Pediatr Orthop; 2014 Dec; 34(8):820-4. PubMed ID: 24590333
[TBL] [Abstract][Full Text] [Related]
6. Langerhans Cell Histiocytosis of the Orbit: Spectrum of Disease and Risk of Central Nervous System Sequelae in Unifocal Cases.
Esmaili N; Harris GJ
Ophthalmic Plast Reconstr Surg; 2016; 32(1):28-34. PubMed ID: 25689784
[TBL] [Abstract][Full Text] [Related]
7. Craniospinal Langerhans cell histiocytosis in children: 30 years' experience at a single institution.
Davidson L; McComb JG; Bowen I; Krieger MD
J Neurosurg Pediatr; 2008 Mar; 1(3):187-95. PubMed ID: 18352762
[TBL] [Abstract][Full Text] [Related]
8. Skeletal involvement in children with Langerhans cell histiocytosis: healing, complications, and functional outcome.
Abdelaal AHK; Sedky M; Gohar S; Zaki I; Salama A; Hassanain O; El Ghoneimy AM
SICOT J; 2020; 6():28. PubMed ID: 32672151
[TBL] [Abstract][Full Text] [Related]
9. Unusual sites of bone involvement in Langerhans cell histiocytosis: a systematic review of the literature.
Reisi N; Raeissi P; Harati Khalilabad T; Moafi A
Orphanet J Rare Dis; 2021 Jan; 16(1):1. PubMed ID: 33388073
[TBL] [Abstract][Full Text] [Related]
10. Craniofacial involvement in Langerhans cell histiocytosis: A review of 44 cases at a single medical center.
Lin TE; Chu YY; Chang TY; Liao HT
J Plast Reconstr Aesthet Surg; 2023 Jul; 82():12-20. PubMed ID: 37148805
[TBL] [Abstract][Full Text] [Related]
11. Clinical features, genomic profiling, and outcomes of adult patients with unifocal Langerhans cell histiocytosis.
Lang M; Cai HC; Lin H; Chang L; Dai JW; Chen J; Duan MH; Zhou DB; Goyal G; Cao XX
Orphanet J Rare Dis; 2023 Nov; 18(1):372. PubMed ID: 38037140
[TBL] [Abstract][Full Text] [Related]
12. Langerhans' cell histiocytosis of the temporal bone in children.
Saliba I; Sidani K; El Fata F; Arcand P; Quintal MC; Abela A
Int J Pediatr Otorhinolaryngol; 2008 Jun; 72(6):775-86. PubMed ID: 18355926
[TBL] [Abstract][Full Text] [Related]
13. Childhood Langerhans cell histiocytosis: a disease with many faces.
Leung AKC; Lam JM; Leong KF
World J Pediatr; 2019 Dec; 15(6):536-545. PubMed ID: 31456157
[TBL] [Abstract][Full Text] [Related]
14. FDG PET-CT in pediatric Langerhans cell histiocytosis.
Jessop S; Crudgington D; London K; Kellie S; Howman-Giles R
Pediatr Blood Cancer; 2020 Jan; 67(1):e28034. PubMed ID: 31599488
[TBL] [Abstract][Full Text] [Related]
15. Langerhans Cell Histiocytosis in the Pediatric Population: Treatment of Isolated Craniofacial Lesions.
Gargano F; Welch JJ; Klinge PM; Sullivan SR; Taylor HO
J Craniofac Surg; 2019 Jun; 30(4):1191-1193. PubMed ID: 31166264
[TBL] [Abstract][Full Text] [Related]
16. MRI and clinical features of Langerhans cell histiocytosis (LCH) in the pelvis and extremities: can LCH really look like anything?
Samet J; Weinstein J; Fayad LM
Skeletal Radiol; 2016 May; 45(5):607-13. PubMed ID: 26802000
[TBL] [Abstract][Full Text] [Related]
17. Clinical features and treatment outcomes of Langerhans cell histiocytosis of the spine.
Xu X; Han S; Jiang L; Yang S; Liu X; Yuan H; Wei F; Wu F; Dang L; Zhou H; Zhang H; Liu Z
Spine J; 2018 Oct; 18(10):1755-1762. PubMed ID: 29505854
[TBL] [Abstract][Full Text] [Related]
18. Outcome of children with Langerhans cell histiocytosis and single-system involvement: A retrospective study at a single center in Shanghai, China.
Su M; Gao YJ; Pan C; Chen J; Tang JY
Pediatr Hematol Oncol; 2018; 35(7-8):385-392. PubMed ID: 30693828
[TBL] [Abstract][Full Text] [Related]
19. Langerhans cell histiocytosis of the temporal bone: A review of 29 cases at a single center.
Modest MC; Garcia JJ; Arndt CS; Carlson ML
Laryngoscope; 2016 Aug; 126(8):1899-904. PubMed ID: 26535795
[TBL] [Abstract][Full Text] [Related]
20. Intensification of induction therapy and prolongation of maintenance therapy did not improve the outcome of pediatric Langerhans cell histiocytosis with single-system multifocal bone lesions: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study.
Morimoto A; Shioda Y; Imamura T; Kudo K; Kitoh T; Kawaguchi H; Goto H; Kosaka Y; Tsunematsu Y; Imashuku S;
Int J Hematol; 2018 Aug; 108(2):192-198. PubMed ID: 29594922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
